Clinical stage pharmaceutical company advancing innovative outpatient options for patients suffering from fluid overload (edema) associated with congestive heart failure(CHF), liver, and kidney disease.
Company Details
- Employees
- 6
- Founded
- 2018
- Address
- 3535 Executive Terminal Way,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.corstasis.com
- Keywords
- Cardiology, Nephrology, Heart Failure.
- HQ
- Henderson, NV
Corstasis Therapeutics Questions
Corstasis Therapeutics's website is http://www.corstasis.com
Corstasis Therapeutics's LinkedIn profile is https://www.linkedin.com/company/corstasis-therapeutics
Corstasis Therapeutics has
6 employees.
View email and phone details for 6
employees at Corstasis Therapeutics.
Corstasis Therapeutics's industry is
Pharmaceutical Manufacturing
Corstasis Therapeutics's top competitors are
Ns Pharma, Inc.,
Verona Pharma,
Fibronostics,
Xeris Pharmaceuticals, Inc.,
Fennec Pharmaceuticals Inc,
Anavex Life Sciences,
Clarity Pharmaceuticals,
Nucleix Ltd.,
Alpha Cognition, Inc.,
Veloxis Pharmaceuticals, Inc..
Corstasis Therapeutics's categories are Pharmaceutical Manufacturing
Corstasis Therapeutics's founding year is 2018
